Skip to main content

Loading market ticker...

Is Mastek’s Order Book (NSE:MASTEK) Growth Signalling Future Revenue Stability?

Is Mastek’s Order Book (NSE:MASTEK) Growth Signalling Future Revenue Stability?

Source: shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn More

Highlights

  • Revenue from operations rose 3.6% YoY to Rs 938.0 crore in Q4FY26.
  • Order backlog expanded 24.4% YoY, reflecting improved medium-term revenue visibility.
  • Net profit increased 30.9% YoY, while EBITDA margin remained at 16.1%.

Mastek Limited (NSE:MASTEK) reported revenue from operations of Rs 938.0 crore in Q4FY26, registering a 3.6% year-on-year increase. On a sequential basis, revenue grew 3.6% from Rs 905.7 crore in Q3FY26. Total income stood at Rs 961.9 crore, up 5.8% YoY.

Operating EBITDA came in at Rs 150.7 crore, reflecting an 8.6% YoY increase, while EBITDA margin stood at 16.1%, compared to 15.3% in Q4FY25. Net profit rose to Rs 106.2 crore, marking a 30.9% YoY growth, though it declined 2.0% sequentially. Net profit margin was reported at 11.0%.

For FY26, revenue from operations increased 7.0% YoY to Rs 3,698.8 crore, while net profit rose 7.5% to Rs 404.0 crore.

Order Book and Deal Momentum

The company’s 12-month order backlog stood at Rs 2,849.2 crore as of March 31, 2026, reflecting a 24.4% YoY increase and 7.2% sequential growth. This indicates improved revenue visibility for the coming quarters.

During the quarter, the company closed over 25 AI-related deals, taking the total to more than 85 deals for FY26. These deals span sectors such as healthcare, financial services, and public sector projects.

Client additions remained steady, with 12 new clients added during Q4FY26, taking the active client base to 326.

Segment and Geographic Performance

The UK business continued to contribute significantly, supported by growth in healthcare and financial services segments. Healthcare revenue in the UK segment grew 95% YoY during FY26.

North America showed early signs of improvement, supported by pipeline expansion and execution-focused initiatives, although management indicated the market remains in transition.

Revenue contribution remained diversified across industries including government, healthcare, retail, manufacturing, and financial services.

Operational Metrics and Workforce

The company reported total employee strength of 4,730 as of March 31, 2026, compared to 4,676 in the previous quarter. Attrition stood at 17.4%, marginally lower than 17.6% in Q3FY26.

Days Sales Outstanding (DSO) improved to 73 days from 84 days sequentially, indicating better working capital efficiency. Cash and cash equivalents increased to Rs 938.5 crore.

Dividend Announcement

The board has recommended a final dividend of Rs 16 per share for FY26, taking the total payout to 480% for the year, compared to 460% in FY25.

Technical Summary

Mastek Limited is trading near ₹1,682.00, down around 3.67% on 20 April 2026, but maintains its position above the 51-day SMA near ₹1,644.43, while the 14-day RSI near 58.00 points. Immediate support is placed in the ₹1,640.00–1,580.00 zone, while resistance is seen near the ₹1,800.00–1,950.00 range.

Source: TradingView

Key Risks

  • Revenue growth remains modest despite increased deal activity and pipeline expansion.
  • Dependence on UK and US markets exposes performance to regional economic conditions.
  • Attrition levels remain elevated, potentially impacting delivery and costs.
  • Margin pressure may persist due to wage revisions and operational expenses.

Summary

Mastek (NSE:MASTEK) reported moderate revenue growth in Q4FY26 with stable margins and higher net profit on a yearly basis. Order backlog expansion and AI deal activity indicate pipeline visibility, while regional performance remains mixed.

Operational metrics such as DSO improved, and cash levels increased. However, sequential profit decline and macro uncertainty continue to remain factors to monitor.

FAQs

  1. What was Mastek’s revenue growth in Q4FY26?
    Mastek reported 3.6% year-on-year revenue growth, with total revenue reaching Rs 938.0 crore during the quarter.
  2. How did profitability change during the quarter?
    Net profit increased 30.9% YoY but declined sequentially, while EBITDA margin remained stable at 16.1%.
  3. What is the current order backlog position?
    The company reported an order backlog of Rs 2,849.2 crore, reflecting 24.4% year-on-year growth.

Unlock Premium Articles for Exclusive Insights!

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

Copyright 2026 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.